Home > Healthcare > Medical Devices > Diagnostic Devices > Antimicrobial Resistance Surveillance Market

Antimicrobial Resistance Surveillance Market Trends

  • Report ID: GMI8340
  • Published Date: Feb 2024
  • Report Format: PDF

Antimicrobial Resistance Surveillance Market Trends

The increasing prevalence of infectious diseases is a significant driver for the antimicrobial resistance (AMR) surveillance industry. As, infectious diseases become more prevalent, there is a greater need for effective treatment. This often leads to increased use of antimicrobial drugs, leading to the likelihood of the development of antimicrobial resistance.
 

  • For instance, according to the Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases increased to 10.2 million.
     
  • Further, infectious diseases with antimicrobial-resistant strains pose a significant public health threat. They can spread more easily and widely, leading to outbreaks and even pandemics. Thus, surveillance is crucial for detecting these resistant strains early, allowing for timely responses such as targeted interventions and infection control measures.
     
  • Moreover, antimicrobial resistance increases the economic burden on healthcare systems. As, treating infections with resistant strains often requires more expensive and complex therapies, and molecular diagnostics. Therefore, surveillance helps in optimizing treatment regimens, reducing unnecessary antibiotic prescriptions, and ultimately saving healthcare costs, thereby augmenting the market growth.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size antimicrobial resistance surveillance reached USD 5.9 billion in 2023 and is set to cross USD 9.8 billion by 2032, attributed to the rising incidence of antimicrobial resistance which has become a significant public health concern globally.

The diagnostic kits segment is estimated to account for USD 4.2 billion by the end of 2032, as they provide rapid and accurate identification of pathogens.

North America market size was USD 2.4 billion in 2023, owing to the presence of a sophisticated healthcare infrastructure, stringent regulations, and rising incidence of antimicrobial resistance.

Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company (BD), Biomereiux SA, Bruker Corporation, Himedia Laboratories Pvt. Ltd., Opgen Inc., Danaher Corporation, Luminex Corporation, Merck & Co., Inc., and Thermo Fisher Scientific Inc.

Antimicrobial Resistance Surveillance Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 215
  • Countries covered: 22
  • Pages: 100
 Download Free Sample